Sherye A. Sirrel
Boston University(US)Alzheimer's Association(US)Banner Alzheimer’s Institute
Publications by Year
Research Areas
Alzheimer's disease research and treatments, Dementia and Cognitive Impairment Research, Functional Brain Connectivity Studies, Bioinformatics and Genomic Networks, Advanced Neuroimaging Techniques and Applications
Most-Cited Works
- → Poor Safety and Tolerability Hamper Reaching a Potentially Therapeutic Dose in the Use of Thalidomide for Alzheimer’s Disease: Results from a Double-Blind, Placebo-Controlled Trial(2017)52 cited
- → Genetic studies of plasma analytes identify novel potential biomarkers for several complex traits(2016)32 cited
- → P3‐453: Rationale and strategy for thalidomide as a BACE 1 inhibitor for a phase II randomized clinical trial in mild‐to‐moderate Alzheimer's disease(2010)3 cited
- → P1–349: A phase II double‐blind, placebo‐controlled randomized trial of an escalating dose of thalidomide in the treatment of Alzheimer's disease: Baseline characteristics(2013)